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Joint Radiofrequency Ablation: What is the Role of the
Second Diagnostic Block?
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Pain Diagnostics and Interventional Care, Sewickley, PA; Advanced Pain Therapy, Hattiesburg, MS

Introduction
Lumbar medial branch (LMB) radiofrequency
ablation (RFA) is a procedure commonly performed
to treat facet joint-mediated pain. One challenge
presented by LMB RFA is appropriately selecting
patients.1 Pain medicine organizations have
recommended using diagnostic dual and
comparative local anesthetic blocks.2,3,4 However,
one must account for associated additional costs,
humanistic factors, and risks of excluding
individuals that may benefit from RFA.3 This study
aims to further elucidate the value of the
second block in providing relevant prognostic
data for appropriately selecting patients for
RFA. Following IRB approval, a retrospective
review was conducted on patients who underwent
at least one lumbar medial branch block (MBB)
procedure from September 2013 to June 2019. A
successful block was defined as resulting in ≥50%
pain relief accompanied by patient satisfaction with
degree of pain relief. Patient dissatisfaction was
defined as pain relief that was ≥50% but below the
degree and/or duration necessary for the patient to
proceed to the second block. In addition to
demographic data, data was gathered on medial
branch blocks, including type of anesthetic as well
as length and degree of relief. Length of pain relief
was defined as the length of time until the reported
numerical pain rating scale (NPRS) for back pain
returned to baseline NPRS (i.e., prior to MBB).
Duration of relief achieved with each local
anesthetic and its influence on successful MBB
outcomes were also evaluated. Adverse events
were recorded. Proportions were compared by
exact binomial tests within categories and Fisher’s
exact test across categories.
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Table 2. Reported degrees of patient pain relief
following first MBB. More than half of patients (54%) had
a successful first block (n=255).
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Table 3. Reported degrees of patient pain relief
following second MBB. 73% of patients had a successful
second block (n=188).
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Demographic Data

Table 1. Demographic data of patients who
underwent lumbar MBB with local anesthetic only
by injection.

Patient Outcomes Based on Pain
Relief Duration from Lidocaine

Figure 1. Relative Frequency Histogram of Patient
Outcomes Based on Pain Relief from Second MBB.
Only patients with >70% pain relief from the first block
experienced significantly (p<0.03) greater pain relief and
satisfaction with the second block. Patients with <50% and
50-70% pain relief from the first block did not experience
significantly greater pain relief with the second block
(p=0.80 and 0.34, respectively), nor was this pain relief
significantly different across groups of patients (p=0.39).
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Figure 2. Relative Frequency Histogram of Patient
Outcomes Based on Duration of Pain Relief from
Lidocaine. For patients who received lidocaine as their
second MBB, a significant proportion (78%, p<0.001) of
patients whose pain relief lasted >4 hours had successful
outcomes. However, only 45% of patients with ≤ 4hrs of
relief were successful following the second block (p=0.71).

Conclusion
A second diagnostic MBB could be deemed valuable if it
significantly alters RFA patient selection and improves
clinical outcomes, but one would need to weigh this benefit
against the additional associated healthcare costs and
humanistic burden of having a patient undergo a second
block. In this study, 54% of patients had a successful first
block, suggesting that facet joints were a source of low
back pain. This proportion is above the accepted published
range of 15-45% for patients with low back pain from facet
joints.5 Combining results from the first and second blocks,
44% of patients had facet joint-mediated pain. Therefore,
the data suggests that some individuals without facet jointmediated pain may have reported a successful first block.
In this study, most patients (73%) who had a
successful first MBB had a successful second MBB. In
individuals experiencing >70% pain relief from the
first block, a second block did not significantly alter
RFA selection (approximately 80% had a positive second
block), suggesting that in this subgroup a second block may
not add additional diagnostic information. Furthermore, this
study questions the benefit of adding comparative local
anesthetic blocks to the selection process. Most individuals
who underwent lidocaine block had >4 hours of pain relief,
which is beyond the suggested pharmacology-based
duration of action for lidocaine (<2 hrs). Also, individuals
with >4 hrs of pain relief from lidocaine were more likely to
report a successful block, a result difficult to define based
on clinical pharmacology. Continued research is needed to
determine whether the second diagnostic block provides
helpful prognostic data that positively influences patient
selection and RFA outcomes.

